Gene Biotherapeutics, Inc.
USD0.00
+0.00 (+9900.00%)
CEO
Christopher J. Reinhard
IPO Date
2000-05-03
Sector
Healthcare
Industry
Biotechnology
Exchange
OTC
Country
US
Open
$0.00
Prev. Close
$0.00
Day Low
$0.00
Day High
$0.00
52W Low
$0.00
52W High
$0.00
Market Cap
$0.00B
Volume
0.01M
| 3.1 |
| 31 Dec 2018 | FY | 0.0% | 0.0% | 8.4% | -268.7% | -0.21 | 0.02 | -1.7 |
| 31 Dec 2017 | FY | 0.0% | 0.0% | 39.4% | -902.9% | -0.26 | 0.01 | -0.8 |
| 31 Dec 2016 | FY | 0.0% | 0.0% | 93.0% | -262.7% | -0.33 | 0.21 | -0.7 |
| 31 Dec 2015 | FY | 0.0% | 0.0% | 97.5% | -9913.4% | -0.25 | 0.01 | -1.1 |
| 31 Dec 2014 | FY | 0.0% | 0.0% | 327.4% | -738.0% | -0.41 | 0.17 | -0.4 |
| 31 Dec 2013 | FY | 36.7% | -8163.3% | -752.2% | -319.9% | 0.00 | 0.31 | -0.7 |
| 31 Dec 2012 | FY | 44.3% | -1059.8% | -130.7% | -106.6% | 0.00 | 3.08 | -2.7 |
| 31 Dec 2011 | FY | 0.0% | 0.0% | -117.2% | -95.0% | 0.00 | 4.13 | -3.5 |
| -1.1 |
| 30 Jun 2020 | Q2 | 0.0% | 0.0% | -14.2% | 32.5% | -0.40 | 0.28 | 0.3 |
| 31 Mar 2020 | Q1 | 0.0% | 0.0% | 3.4% | -115.7% | -0.27 | 0.02 | -3.6 |
| 31 Dec 2019 | Q4 | 0.0% | 0.0% | -33.8% | 4092.0% | -0.26 | 0.01 | 0.5 |
| 30 Sept 2019 | Q3 | 0.0% | 0.0% | 2.3% | -195.0% | -0.20 | 0.01 | -4.4 |
| 30 Jun 2019 | Q2 | 0.0% | 0.0% | 4.0% | -540.8% | -0.18 | 0.00 | -2.0 |
| 31 Mar 2019 | Q1 | 0.0% | 0.0% | 4.0% | -359.1% | 0.00 | 0.00 | -1.9 |
| 31 Dec 2018 | Q4 | 0.0% | 0.0% | 4.7% | -149.5% | -0.21 | 0.02 | -0.8 |
| 30 Sept 2018 | Q3 | 0.0% | 0.0% | -8.0% | 143.0% | -0.23 | 0.04 | 0.7 |